BH3-mimetics: recent developments in cancer therapy
Abstract The hopeful outcomes from 30 years of research in BH3-mimetics have indeed served a number of solid paradigms for targeting intermediates from the apoptosis pathway in a variety of diseased states. Not only have such rational approaches in drug design yielded several key therapeutics, such...
Guardado en:
Autores principales: | Paul A. Townsend, Maria V. Kozhevnikova, Olivier N. F. Cexus, Andrey A. Zamyatnin, Surinder M. Soond |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8ca444f31899451e9516bb1912adb4ea |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Functional apoptosis profiling identifies MCL-1 and BCL-xL as prognostic markers and therapeutic targets in advanced thymomas and thymic carcinomas
por: Denise Müller, et al.
Publicado: (2021) -
SMAC Mimetics as Therapeutic Agents in HIV Infection
por: Bengisu Molyer, et al.
Publicado: (2021) -
The hermeneutical dimension of the bioethical enterprise. Notes on the dialogical/narrative foundations of bioethics
por: Lolas Stepke,Fernando
Publicado: (2018) -
Inhibition of the Anti-Apoptotic Bcl-2 Family by BH3 Mimetics Sensitize the Mitochondrial Permeability Transition Pore Through Bax and Bak
por: Pooja Patel, et al.
Publicado: (2021) -
Mechanisms and Effects of Dietary Restriction on CNS and Affective Disorders
por: Haritov E., et al.
Publicado: (2020)